Roswell, GA, United States of America

Chih-Min Kam

This inventor holds 6 USPTO granted patents. Top assignee: Georgia Tech Research Corporation. Active years: 1989-1994.


% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1989-1994

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Chih-Min Kam

Introduction

Chih-Min Kam is a notable inventor based in Roswell, GA (US). He has made significant contributions to the field of biochemistry, particularly in the development of serine protease inhibitors. With a total of six patents to his name, Kam's work has implications in both therapeutic and research applications.

Latest Patents

Among his latest patents are "Substituted isocoumarins as serine protease inhibitors" and "Substituted isocoumarins, their use in inhibiting serine proteases with trypsin-like, chymotrypsin-like and elastase-like specificity and their roles as anti-inflammatory agents." Additionally, he has developed "Biotinylated isocoumarins - Biotinylated isocoumarins, their use in inhibiting serine proteases with chymotrypsin-like and elastase-like specificity and in purifying proteins." These innovations highlight his focus on creating effective inhibitors that can be utilized in various biochemical processes.

Career Highlights

Chih-Min Kam is affiliated with the Georgia Tech Research Corporation, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a deep understanding of biochemical interactions.

Collaborations

Some of his notable coworkers include James C Powers and Josef Oleksyszyn. Their collaborative efforts contribute to the success of the projects they undertake together.

Conclusion

Chih-Min Kam's contributions to the field of biochemistry through his patents and research at Georgia Tech Research Corporation underscore his role as a leading inventor in the development of serine protease inhibitors. His work continues to influence both academic and practical applications in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…